Vistagen Therapeutics Announces Board Resignations of Margaret FitzPatrick and Dr. Joanne Curley
On June 16 and June 17, 2026, Vistagen Therapeutics, Inc. received notifications from two members of its Board of Directors regarding their departures. Ms. Margaret FitzPatrick and Dr. Joanne Curley both informed the Company of their decisions not to stand for re-election at the Companyβs upcoming 2026 Annual Meeting of Stockholders. According to the filing, both Ms. FitzPatrick and Dr. Curley will continue to serve in their current roles as directors until their respective terms conclude at the 2026 Annual Meeting. The filing did not specify any disagreements between the departing directors and the Company regarding operations, policies, or practices. The Company has not yet announced any successors or specific plans regarding the composition of the Board following the 2026 Annual Meeting. This transition marks a change in the governance structure as the company approaches its next annual meeting cycle.